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Irritable bowel syndrome (IBS) after previous episode of infectious enteritis is
now well recognized and defined as one subgroup of postinfectiously IBS (PI-
IBS). The incidence of PI-IBS has been reported to be between 4 and 31%.
1-7
Intestinal mucosa has abundant immune system, called physiologically inflama-
tory status. For many years, low grade inflammation was considered to have a
role in IBS. There are many studies investigating inflammation in mucosal
biopsy from terminal ileum to rectum in IBS. Mast cells were increased
8-12 and
located close to mucosal nerve endings within 2-5 µm.
11,12 Mast cell numbers in
close proximity to nerves were correlated with IBS symptoms.
11 Increased cel-
lularity, including T lymphocytes, has also been shown in IBS.
13  PI-IBS is
Original Article
DOI 10.3349/ymj.2010.51.1.45
pISSN: 0513-5796, eISSN: 1976-2437 Yonsei Med J 51(1): 45-51, 2010
Increased Immunoendocrine Cells in Intestinal Mucosa
of Postinfectious Irritable Bowel Syndrome Patients 
3 Years after Acute ShigellaInfection 
- An Observation in a Small Case Control Study
Hee Sun Kim, Jung Hyun Lim, Hyojin Park, and Sang In Lee 
Department of Internal Medicine, Yonsei Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.
Purpose: Postinfectiously irritable bowel syndrome (PI-IBS) develops in 3-30% of individuals with bacterial
gastroenteritis. Recent studies demonstrated increases in inflammatory components in gut mucosa of PI-IBS
patients even after complete resolution of infection. We aimed to investigate histological changes in colon and
rectum of PI-IBS subjects after long term period of infection. Materials and Methods: We recruited PI-IBS
subjects who had been diagnosed IBS after complete resolution of enteritis caused by shigellosis outbreak 3 years
earlier. We compared unmatched four groups, PI-IBS (n = 4), non PI-IBS (n = 7), D-IBS (n = 7, diarrhea predo-
minant type) and healthy controls (n = 10). All of them underwent colonoscopic biopsy at three areas, including
descending colon (DC), sigmoid colon (SC) and rectum, which were assessed for 5-hydroxytryptamine (5-
HT)/peptide YY (PYY)-containing enterochromaffin (EC) cell, intraepithelial (IEL) and lamina propria T lymphocyte
(CD3), CD8 lymphocytes, mast cells and CD68/calprotectin+ macrophages. Results: All subjects had no structural
or gross abnormalities at colonoscopy. In PI-IBS, 5-HT containing EC cells, PYY containing EC cells, IELs, CD3
lymphocytes, CD8 lymphocytes, mast cells, and CD68 + macrophages were increased compared to control (p <
0.05). In D-IBS, PYY containing EC cells, IELs, and CD3 lymphocytes were increased compared to control (p <
0.05). In PI-IBS, 5-HT containing EC cells tended to increase and PYY containing EC cells, CD8 lymphocytes,
mast cells, and CD68+ macrophages were increased compared to non PI-IBS (p < 0.05). Calprotectin + marcro-
phages were decreased in PI-IBS, non PI-IBS and IBS compared to control. Conclusion: The immunoendocrine
cells were sporadically increased in PI-IBS, non PI-IBS and D-IBS compared with control. Our findings in a very
small number of patients suggest that mucosal inflammation may play a role in long-term PI-IBS, and that other
sub-groups of IBS and larger scale studies are needed to confirm this observation. 
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INTRODUCTIONsubcategorized under the concept that morphologically
normal intestine after recovery from acute infection has
abnormal function, inducing IBS symptoms. However,
only a few biopsy studies have been reported in PI-IBS
patients. Spiller, et al. first defined the pathological basis of
PI-IBS that increased enterochromaffin (EC) cells, and T
lymphocytes during the acute period of enteritis can persist
for more than a year. Up to date, there is no case-control,
long term follow up study about the histologic assessment
of PI-IBS. We previously reported the incidence of PI-IBS
in a single hospital after 3 years of shigellosis outbreak.
14
In this homogenous group, 13 cases (14.9%) had IBS after
3 years of infection. 
In this study, we aim to investigate mucosal immunohis-
tologic change in PI-IBS after long time period of infection.
We assessed EC cells, lymphocytes, mast cells and macro-
phage numbers. Microscopic colitis (MC), including lym-
phocytic colitis (LC) and collagenous colitis (CC), is a
common cause of chronic diarrhea.
15,16 About 50% of  IBS
had microscopic inflammation compatible with MC,
13 and
about 41-56% of MC patients were diagnosed as IBS by
IBS criteria.
17 Therefore, we also counted intraepithelial T
lymphocyte to exclude lymphocytic colitis. We examined
mucosal histology in non PI-IBS who had normal bowel
function after shigella infection, out-patient IBS, and control
as well as PI-IBS.
Subjects
In November 2001, there was a shigellosis outbreak at
Yongdong Severance Hospital in Seoul. We obtained the
list of infected subjects and reported the prevalence of PI-
IBS after 3, 6, and 12 months of infection.
18 Three years
later, we then reported long term follow up data about the
prevalence of PI-IBS.
14 PI-IBS was defined who had normal
bowel habit before infection and met Rome II criteria for
IBS after shigellosis. All of them had at least 2 of the
followings during acute illness; fever, vomiting, diarrhea
or positive stool culture. Non PI-IBS was defined as a sub-
ject who had normal bowel habit before and after shigel-
losis. We also recruited patients who met the Rome II
criteria for IBS, especially diarrhea-predominant type
without history of acute enteritis. All subjects calssified as
PI-IBS, non PI-IBS, diarrhea predominant IBS (D-IBS),
and controls underwent screening colonoscopy. Under
colonoscopy, we excluded patients with organic diseases
such as inflammatory bowel disease, tuberculosis intestine,
or colon cancer. However, we included colonic adenoma or
polyps under 1 cm as well as anal diseases such as hemorr-
hoid. All participants in this study gave an informed consent.
This study protocol was approved by the Ethics Committee,
Yonsei University College of Medicine.
Colonic and rectal biopsy
All subjects underwent colonoscopy after bowel prepara-
tion with conventional sodium phosphate. Two biopsies
each were obtained from descending colon, sigmoid colon
and rectum using endoscopic biopsy forceps (FB-13K-1,
Olympus, Tokyo, Japan). 
Immunohistochemistry
The biopsy specimens were fixed in 4% formaldehyde.
This paraffin block was cut at  4 µm thickness and mounted
onto poly-L-lysine coated slides. For deparaffinization, the
fixed paraffin-embedded section was dehydrated with
xylene for 45 min at 60˚C. Then, the tissue was successi-
vely rehydrated with 100%, 90%, and 70% alcohol, and
heated in a microwave for 10 min to retrieve antigen, at
which point cooling was achieved at room temperature. The
slide was rinsed with 0.02 M phosphate buffered saline
(PBS) for 10 min. Sections were immersed in 3% hydrogen
peroxide for 10 minutes to block endogenous peroxidase
activity. The tissue was incubated with the following
primary antibodies; 5-hydroxytryptamine (5-HT) (mono-
clonal antibody, DAKO, Cambridge, UK, 1 : 50), peptide
YY (PYY) (monoclonal antibody, abcam, 1 : 400), CD3
(polyclonal antibody, DAKO, 1 : 25), CD8 (lyophilized
monoclonals, DAKO, 1 : 5), mast cell tryptase (monoclonal
antibody, DAKO, 1 : 250), CD 68 (monoclonal antibody
DAKO, 1 : 100), and calprotectin (monoclonal antibody,
DAKO, 1 : 200). Sections were washed with PBS and
incubated with secondary antibodies within biotinylated
goat antimouse and antirabbit antibody (DAKO, Cam-
bridge, UK). The sections were washed with PBS and
incubated for 30 minutes with streptavidin (DAKO, 1 : 200,
room temperature, 30 minutes). After washing with PBS,
the sections were processed with 3-amino-9-ethyl-carbazole
(AEC) chromogen solution for 10 minutes and counters-
tained with Mayer’s hematoxylin for 30 seconds. 
Cell counting
The immunostained cells were examined at labeled 3
anatomic regions: descending colon, sigmoid colon, and
rectum. The numbers of 5-HT positive EC cells and CD3
positive intraepithelial T lymphocytes (IEL) per 100
epithelial cells were counted in 5 areas, and then averaged.
The numbers of PYY positive EC cells, T lymphocytes
(CD3), CD8 lymphocyte, mast cells (mast cell tryptase),
resident macrophages (CD68) and reactive macrophage
(calprotectin) were counted  within high power filed, 400
µm×400 µm in lamina propria. The counts under 5 fileds
were averaged.
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Statistic analysis
Data were presented as mean ± SE. Comparisons were
made using Kruskall-Wallis test and Mann-Whitney U test
for nonparametric data, using SPSS for Windows version
12.0 (SPSS Inc., Chicago, IL, USA). p < 0.05 was consi-
dered significant.
Patients (Table 1)
Total 28 subjects were included in this study. Thirteen
patients were compatible with PI-IBS, but only four of them
Table 1.Characteristcs of Patients and Controls
PI-IBS Non PI-IBS IBS Control
Numbers 4 7 7 10
Age (year) 30 ± 5.1 51 ± 5.6 38 ± 10.0 48 ± 6.9
Gender (M : F) 2 : 2 7 : 0 5 : 2 5 : 5
Subtype numbers
Diarrhea 2 7
Constipation 1 0
Alternating 1 0
PI-IBS, postinfectious irritable bowel syndrome; IBS, irritable bowel syndrome.
Table 2.Histologic Findings
PI-IBS non PI-IBS IBS Control pvalue
5-HT DC 1.40 ± 0.36* 0.69 ± 0.13 0.94 ± 0.21 0.52 ± 0.16 0.073
SC 1.55 ± 0.55 1.35 ± 0.35 0.66 ± 0.14 0.43 ± 0.13 0.039
Rec 2.15 ± 0.30* 1.14 ± 0.28 1.04 ± 0.37 0.63 ± 0.20 0.055
Peptide YY DC 4.5 ± 1.11
� 1.39 ± 0.37 8.25 ± 2.09
� 3.74 ± 0.86 0.006
SC 16.23 ± 6.73 3.29 ± 0.87 5.43 ± 0.64 6.78 ± 1.46 0.166
Rec 23.90 ± 6.52*� 7.17 ± 1.43 10.98 ± 5.33 7.20 ± 1.61 0.119
IEL DC 17.5 ± 7.53 9.23 ± 1.20 10.12 ± 1.38 7.24 ± 1.32 0.355
SC 13.41 ± 5.57 7.22 ± 1.20 11.49 ± 1.31
� 5.91 ± 0.82 0.024
Rec 11.40 ± 4.17* 5.83 ± 0.73 8.19 ± 0.73
� 4.77 ± 0.85 0.033
CD3 DC 30.45 ± 3.09* 25.97 ± 4.57 25.90 ± 3.77
� 17.69 ± 5.82 0.024
SC 29.80 ± 7.37* 24.09 ± 3.07 25.51 ± 3.20
� 13.82 ± 2.83 0.039
Rec 25.05 ± 2.96* 25.31 ± 3.57 20.67 ± 1.29
� 14.89 ± 1.53 0.013
CD8 DC 69.00 ± 10.87*� 36.11 ± 3.91 35.00 ± 5.37 32.56 ± 18.57 0.031
SC 73.29 ± 15.38* 47.66 ± 11.54 36.07 ± 10.30 21.92 ± 10.15 0.046
Rec 42.20 ± 16.39 35.95 ± 4.79 44.06 ± 13.24 21.34 ± 10.33 0.259
Mast cell  DC 105.3 ± 13.33*� 52.89 ± 13.44 40.86 ± 10.32 59.24 ± 12.83 0.064
SC 77.40 ± 33.29 41.6 ± 9.73 45.66 ± 13.35 55.29 ± 12.40 0.793
Rec 76.35 ± 18.05 39.17 ± 11.73 38.57 ± 9.39 36.56 ± 8.88 0.234
CD68 DC 39.40 ± 8.48
� 19.63 ± 2.34 33.49 ± 9.90 25.64 ± 5.41 0.339
SC 33.35 ± 6.71* 29.80 ± 8.07 33.40 ± 8.16 31.56 ± 7.60 0.896
Rec 75.30 ± 15.30*� 25.69 ± 7.25 41.09 ± 8.83 35.64 ± 7.04 0.074
Calprotectin DC 4.50 ± 2.37* 5.37 ± 1.65 1.30 ± 0.52
� 21.85 ± 6.09 0.007
SC 1.05 ± 0.71 2.29 ± 1.00 4.30 ± 2.01 15.43 ± 6.71 0.06
Rec 0.75 ± 0.62* 2.49 ± 1.50 1.14 ± 0.46
� 17.60 ± 11.00 0.028
PI-IBS, postinfectious irritable bowel syndrome; IBS, irritable bowel syndrome; 5-HT, 5-hydroxytryptamine. 
Cell counts/100 epithelial cells for 5-HT, IEL. Cell counts / 160,000 µm2for peptide YY, CD3, mast cell, CD68, calprotectin.
*PI-IBS vs. control, pvalue < 0.05, Mann Whitney U test.
�IBS vs. control, pvalue < 0.05, Mann Whitney U test.
�PI-IBS vs non PI-IBS, pvalue < 0.05, Mann Whitney U test.
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agreed to undergo colonoscopic biopsy. There were 2 diar-
rhea, one constipation, and one alternating subtype in this
group. We collected 64 non PI-IBS subjects. About half of
them left the hospital or moved out. Most of the remainder
refused the exam because they had no IBS symptoms and
fear of colonoscopy. Only 7 middle-aged women agreed to
enroll as non PI-IBS. Diarrhea- predominant IBS patients
were recruited from outpatients in clinic. Thirteen D-IBS
subjects underwent colonoscopy, but finally 7 patients agreed
to use specimen in our research. Finally, 10 volunteers
were enrolled as controls. 
Histology (Table 2)
PI-IBS and control (Fig. 1)
The main findings were remarkable increase of all mucosal
markers and decrease of calprotectin positive cells in
patients with PI-IBS, compared to control. EC cells were
stained for 5-HT or PYY, both of which were increased in
colon and rectum. IEL were more than twice the cotrol
counts, but less 20/100 surface epithealial cells. Microsco-
pic colitis can be diagnosed if IEL counts are over this de-
gree.
17 CD3 and CD8 positive lymphocyte counts in lamina
propria were also elevated. Mast cells were increased in all
areas. CD68 positive macrophages were increased, whereas
calprotectin positve cells representing recently emigrated
monocytes were decreased. 5-HT positive EC cell numbers
showed negative correlation with CD3 lymphocyte numbers
in lamina propria (r = -0.64, p = 0.025). There were no
correlations between other mucosal markers.
D-IBS and control
EC cells stained for only PYY was increased in D-IBS
patients, compared to control. CD3 positive lymphocyte
Fig. 1. Differences of counts of cellular markers between PI-IBS and controls. There were significant increase of all mucosal markers and
decrease of calprotectin positive cells in patients with PI-IBS, compared to control. PI-IBS, postinfectious irritable bowel syndrome; IEL,
intraepithelial. *p< 0.05, Cell counts/100 epithelial cells for 5-HT, IEL. Cell counts/160,000 µm2for peptide YY, CD3, mast cell, CD68, calprotectin.
Fig. 2.Differences of counts of cellular markers between PI-IBS and non PI-IBS. EC cells stained for PYY, CD8 positive lymphocytes, mast cells and
CD68 positive macrophages were increased in PI-IBS patients, compared to non PI-IBS group. 5-HT positive EC cells showed increased tendency
in PI-IBS group compared to non PI-IBS group. (p= 0.085 in DC, p= 0.058 in rectum). PI-IBS, postinfectious irritable bowel syndrome; PPY, peptide
YY; IEL, intraepithelial. * p< 0.05. Cell counts/100 epithelial cells for 5-HT, IEL. Cell counts/160000 µm2for PYY, CD3, mast cell, CD68, calprotectin.counts in lamina propria and IELs were both elevated. IEL
numbers were not over 20/100 surface epithealial cells.
Calprotectin positive cells were decreased in D-IBS.
PI-IBS, non PI-IBS and control 
In non PI-IBS group, 5-HT positive EC cells, and lamina
propria CD3 lymphocytes were increased compared to
controls. Similar to PI-IBS and D-IBS patients, calprotectin
positive cells were also decreased in non PI-IBS group. In
PI-IBS patients, EC cells which were stained for 5-HT and
PYY, CD8 positive lymphocytes, mast cells and CD68
positive macrophages were increased, compared to non PI-
IBS group (Fig. 2).
To our best knowledge, this is the first case control study
to compare immunohistological features after long-term
resolution of acute infectious enteritis. We confirmed that
the acute inflammatory or endocrine change can persisit
over three years in gut mucosa, independent on IBS sym-
ptoms. The most interesting finding in this study was that,
although there was a difference in degree of changes among
PI-IBS, non PI-IBS and D-IBS groups, low grade inflam-
mation and increased enteroendocrine cells were found
definitely in those groups. 
What would play an important role in developing symp-
toms in post infectious IBS patients? We found cellular
differences between PI-IBS and non PI-IBS groups. Both
groups had common history of enteritis caused by same
organisms. Enteric pathogen can induce tight junction dis-
ruption, thereby contributing to the development of secre-
tory abnormality and activation of further immunologic
responses.
19 Increased permeability allows antigens to easily
enter through gut mucosa, which results in inflammatory
cascade characterized by increase of various immune
cells.
20 However, the role of increased gut permeability in
IBS symptoms is not yet unclear. We suggest that broken
gut barrier might closely be related to longstandinging
inflammatory environment in gut mucosa. Many other
functional gastrointestinal disorders develop after acute
infection.
21-23 Furthermore, inflammatory response can
affect neural and motor functions, consequently inducing
hypersensitivity or irritability.
24 However, we also found
clear changes of some marker cells in non PI-IBS, and
thought that cellular difference between PI-IBS and non
PI-IBS groups would be related to the development of  PI-
IBS. In this study, 5-HT containing EC cells, PYY contain-
ing EC cells, CD8-lymphocytes, mast cells, and resident
macrophages were abundant more in PI-IBS group. Pre-
viously, persistently increased EC cell numbers were
found in PI-IBS
25,26:  EC cells, CD3 lymphocytes and IEL
counts were increased in PI-IBS patients after 1 year of
campylobacter enteritis. However, there were no control or
non PI-IBS groups to be compared.
25 Dunlop, et al.
2 showed
that 5-HT containing EC cells, and T lymphocytes in lamina
propria were significantly increased in PI-IBS compared to
non PI-IBS in rectal biopsy 3 month after campylobacter
enteritis. 5-HT has been investigated along with its receptors
as target molecules to treat functional gastrointestinal
disorders. Most of 5-HT is found in enterochromaffin cells
which are best characterized subset of enteroendocrine
cells.
27 5-HT activates gastrointestinal motility through 5-
HT3 or 5-HT4 receptors and induces gastric relaxation
through 5-HT7 receptors.
28 PYY is a gastrointestinal
hormone, released from the endocrine cells which are
distributed mainly in the distal ileum, colon and rectum.
29
As shown in the present study, 5-HT containing EC cells
were found to be increase in both groups but more in PI-
IBS, whereas PYY containing EC cells were elevated only
in PI-IBS group. PYY inhibits intestinal motility and
increases postprandial colonic absorption of water and
electrolyte.
29 Postprandial increase in plasma PYY levels
was consistent with the increase of PYY containing cell
numbers after total colectomy.
30 Mucosa can be destroyed
by major surgery or severe enteritis. We suggest, therefore,
that initial destruction of mucosal barrier induces diarrrhea
and cellular adaptation, which can persist for a long time.
Because both 5-HT and PYY are involved in gut motility
and secretion, their plama levels and various receptor func-
tions may be related to development of IBS symptoms. 
Mast cells release potent inflammatory mediators which
are related to visceral hypersensitivity.
10,11 Especially, mast
cell tryptase is considered to develop visceral hypersen-
sitivity and increase gut permeability via protease-activated
receptor (PAR).
31 Longstanding increase of gut permea-
bility and gut hypersensitivity are common in PI-IBS.
19
However, the pathophysiologic role of mast cell tryptase in
these phenomena remains unclear. 
In view of immunologic activation, increased CD8
lymphocytes and resident macrophages and decreased
calprotectin positive cells in laminal propria can not easily
be explained. In acute phase of campylobacter enteritis,
striking increase of CD8 lymphocytes and fall of resident
macrophages were found and they were gradually recover-
ed after 12 weeks.
25 On the other hand, calprotectin positive
cells showed inverse pattern.
25 Memory T cells in lamina
propria are rich source of cytokines and primary trigger of
an immune response. However, intraepithelial CD8 lym-
phocytes are generally anergic in the gut, and selectively
activated to express suppressor function without cytolytic
activity.
32 Macrophages expressed by CD68 in normal
lamina propria are L1 protein (calprotectin) negative.
33 CD68
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DISCUSSION+ L1 + macrophages are recruited from blood only to mo-
derately and severely inflammed areas against microbial
invasion.
33,34 Under steady state, resident monocytes func-
tion as sensors to monitor danger signals and contribute to
the maintenance of macrophages.
35 A differentiation of
emigrating monocytes into intestinal macrophages with
functional anergy may be decisive for intestinal mucosal
integrity.
36 We suggest that both CD8 lymphocytes and
resident macrophages in resolution state of inflammation
in PI-IBS are increased excessively for a long time to
maintain steady state as well as prepare to be activated
againt dangerous antigens. It is quite certain that other cells
whose numbers were increased might also be involved in
this process. The possibility of in situ activation of resident
macrophage into L1 positive form should be investigated.
In the present study, CD3 lymphocyte counts in lamina
propria and 5-HT containing EC cells were elevated both
in PI-IBS and non PI-IBS. Lamina propria T cells are
mostly memory cells.
32 Therefore, non PI-IBS groups might
possibly switch over to PI-IBS groups, compared to normal
controls, if immunoendocrine balance is broken by various
reasons such as psychologic stress. 
In the present study, 5-HT positive EC cell numbers
were found to be negatively correlated with CD3 lympho-
cytes in lamina propria of PI-IBS. In other study, however,
they were shown to be positively corelated at enteritis
phase, but then not 12 weeks later.
25 EC cell numbers are
controlled by Th1 or Th2 predominance.
37 Th2 predomi-
nant condition induces EC cell hyperplasia and 5-HT
contents.
37 On the other hand, Th1 response which is known
to be related to macrophage activation diminishes the EC
cell numbers.
37 Although both cells were increased in PI-
IBS, relatively small increase in EC cells could be related
to this Th1/Th2 balance. The correlation among the acti-
vation of resident macrophages, memory T cell function
and EC cell proliferation should be investigated further.
We also compared D-IBS groups with controls. There
wasn’t even increase of all cell types like PI-IBS. Although
there are many reports to reveal the increase of 5-HT con-
taining EC cells and mast cells in IBS patients, there are
also data that could not prove the relation of those cells
with IBS.
26,38 In our study, PYY containing EC cells, IEL,
and CD3 lymphocyte in lamina propria were increased,
whereas calprotectin positive macrophages were decreased
in D-IBS patients. Because D-IBS groups had no history
of enterocolitis, they did not experience severe mucosal
destruction. There could be a fluctuation in PYY cell num-
bers, depending on manifestation period of diarrhea or
chronic adaptive hyperplasia of cells. Chronic immune
activation by increased T cells may persist in epithelium
and lamina propria of IBS.
38,39 Calprotectin positive cells
can be recruited in acute pathologic state. Consequently,
we expect that this cell numbers are just above or below
normal level, but definitely decreased compared to control.
We should investigate further to find biological significance
of decrease of calprotectin positive macrophages in long-
standing low grade inflammatory area in the gut.
Finally, small numbers of enrolled patients and unma-
tched control group are the inevitable limitation of our
study. This is a feasibility study. We used the statistic tools
to compare groups, but not used the term significant.
However, all subjects who experienced shigella infection
were employees or students in a single hospital, therefore,
they are homogenous groups: same infectious organism,
follow up period, and ordinary environment. Furthermore,
this is the first case-controlled study about long-term
mucosal histopathologic changes after enteric infection. 
In conclusion, we found that immunoendocrine activation
by enteric infection persisted for a long time, at least three
years. Once destroyed, immunologic steady state might not
be completely normalized. Therefore, we should be more
concerned about normal-looking patients who have history
of infectious enterocolitis. Although both PI-IBS and D-
IBS patients have IBS symptoms and colonoscopically
normal mucosa, immunoendocrine network seems to be
variously activated in PI-IBS.
This study was supported in part by a research fund from
Department of Internal Medicine, Gangnam Severance
Hospital.
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